Read news on ESMO with our app.
Read more in the app
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - EurekAlert!
ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients - EurekAlert!
ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients - EurekAlert!
ESMO 2025: A glimpse into the congress program - EurekAlert!
ESMO Gynaecological Cancers Congress 2025: Event announcement - EurekAlert!
ESMO releases version 2.0 of the Magnitude of Clinical Benefit Scale - EurekAlert!
SOPHiA GENETICS presents ground-breaking multimodal research on AI-driven patient stratification at ESMO 2024 - EurekAlert
ESMO: Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in first-in-human trial - EurekAlert
SOPHiA GENETICS announces poster presentations at ESMO 2024 - EurekAlert